Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Return on Equity (2018 - 2025)

Arcus Biosciences (RCUS) has 8 years of Return on Equity data on record, last reported at 0.52% in Q4 2025.

  • For Q4 2025, Return on Equity changed N/A year-over-year to 0.52%; the TTM value through Dec 2025 reached 0.52%, changed N/A, while the annual FY2023 figure was 0.55%, 19.0% down from the prior year.
  • Return on Equity reached 0.52% in Q4 2025 per RCUS's latest filing, down from 0.41% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.11% in Q3 2022 and bottomed at 0.63% in Q4 2023.
  • Average Return on Equity over 5 years is 0.34%, with a median of 0.41% recorded in 2025.
  • Peak YoY movement for Return on Equity: soared 60bps in 2022, then crashed -65bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.08% in 2021, then crashed by -615bps to 0.39% in 2022, then plummeted by -59bps to 0.63% in 2023, then rose by 28bps to 0.45% in 2024, then dropped by -15bps to 0.52% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.52% in Q4 2025, 0.41% in Q3 2025, and 0.55% in Q2 2025.